KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Short-term Investments: 2010-2011

Historic Short-term Investments for Quest Diagnostics (DGX) over the last 1 years, with Dec 2011 value amounting to $56.5 million.

  • Quest Diagnostics' Short-term Investments rose 439.16% to $56.5 million in Q4 2011 from the same period last year, while for Dec 2011 it was $56.5 million, marking a year-over-year increase of 439.16%. This contributed to the annual value of $56.5 million for FY2011, which is 439.16% up from last year.
  • Latest data reveals that Quest Diagnostics reported Short-term Investments of $56.5 million as of Q4 2011, which was up 4.03% from $54.3 million recorded in Q3 2011.
  • In the past 5 years, Quest Diagnostics' Short-term Investments registered a high of $56.5 million during Q4 2011, and its lowest value of $10.5 million during Q4 2010.
  • Its 2-year average for Short-term Investments is $35.1 million, with a median of $36.6 million in 2011.
  • Data for Quest Diagnostics' Short-term Investments shows a peak YoY soared of 439.16% (in 2011) over the last 5 years.
  • Quarterly analysis of 2 years shows Quest Diagnostics' Short-term Investments stood at $10.5 million in 2010, then skyrocketed by 439.16% to $56.5 million in 2011.
  • Its Short-term Investments was $56.5 million in Q4 2011, compared to $54.3 million in Q3 2011 and $18.9 million in Q2 2011.